volume 94 pages 103348

New quinoline-2-one/pyrazole derivatives; design, synthesis, molecular docking, anti-apoptotic evaluation, and caspase-3 inhibition assay

Samia M Sayed 2
Elshimaa M N Abdelhafez 3
Sara Mohamed Naguib Abdel Hafez 4
Mohamed A. Raslan 2
Amira S. Ahmed 2
Khaled Thabet 6
Ahmed A. M. El-Reedy 7
Alan Brown 8
Publication typeJournal Article
Publication date2020-01-01
scimago Q1
wos Q1
SJR0.786
CiteScore8.3
Impact factor4.7
ISSN00452068, 10902120
Organic Chemistry
Drug Discovery
Biochemistry
Molecular Biology
Abstract
• Synthesis of new pyrazolo-quinoline-2-ones. • NMR spectra as effective tool to elucidate the given structure. • Some compounds showed significant improvement for oxidative stress parameters MDA, SOD, GSH and NOx in comparison with model group and greater than NAC. • Colonic histopathological investigation was performed on all targeted compounds. • H&E sections of some compounds revealed apparent normal colonic cells compared with NAC. • Docking studies with caspase-3 revealed that most of the tested compounds showed good binding with the enzyme. We report the synthesis of new quinoline-2-one/pyrazole hybrids and their antiapoptotic activity. This effect was studied in sight of decreasing tissue damage induced by I/R in colon of rats using N -acetylcysteine (NAC) as anti-apoptotic reference. Compounds 6a , 6c and 6f showed significant improvement for oxidative stress parameters MDA, SOD, GSH and NOx in comparison with model group and greater than the reference NAC ( N -acetylcysteine), whereas compounds 6d and 6e exhibited weaker antioxidant activity when compared with the reference NAC. Moreover, compounds 6a, 6c and 6f showed significant decrease in inflammatory mediators TNFα and CRB greater than NAC when compared to the model group especially compound 6c whose found CRB conc 1.90 (mg/dL) in comparison to NAC of conc 2.13 mg/dL. Additionally, colonic histopathological investigation was performed to all targeted compounds that indicates H&E sections of compounds 6a and 6f revealed apparent normal colonic cells while compound 6e showed dilated blood vessels with more apoptotic cells if compared with NAC. Caspase-3 inhibition assay revealed that compounds 6a , 6b and 6d weaken caspase-3 expression to an extent higher than NAC (1.063, 0.430, 0.731 and 1.115, respectively). Docking studies with caspase-3 revealed that most of the tested compounds showed good binding with the enzyme especially for compound 6d make several interactions better than that of the reference NAC.
Found 
Found 

Top-30

Journals

1
2
3
4
5
Molecules
5 publications, 15.63%
Bioorganic Chemistry
2 publications, 6.25%
Current Organic Synthesis
1 publication, 3.13%
Anti-Cancer Agents in Medicinal Chemistry
1 publication, 3.13%
Antioxidants
1 publication, 3.13%
Naunyn-Schmiedeberg's Archives of Pharmacology
1 publication, 3.13%
Structural Chemistry
1 publication, 3.13%
European Journal of Medicinal Chemistry
1 publication, 3.13%
Chemical Data Collections
1 publication, 3.13%
Applied Organometallic Chemistry
1 publication, 3.13%
Journal of Biomolecular Structure and Dynamics
1 publication, 3.13%
Journal of Pharmacy and Pharmacology
1 publication, 3.13%
Zeitschrift fur Naturforschung - Section B Journal of Chemical Sciences
1 publication, 3.13%
Annals of Science and Technology
1 publication, 3.13%
Advances in Heterocyclic Chemistry
1 publication, 3.13%
Monatshefte fur Chemie
1 publication, 3.13%
Scientific Reports
1 publication, 3.13%
Current Enzyme Inhibition
1 publication, 3.13%
ACS Omega
1 publication, 3.13%
3 Biotech
1 publication, 3.13%
Heliyon
1 publication, 3.13%
International Journal of Molecular Sciences
1 publication, 3.13%
Mini-Reviews in Medicinal Chemistry
1 publication, 3.13%
Beni-Suef University Journal of Basic and Applied Sciences
1 publication, 3.13%
Environmental Science and Pollution Research
1 publication, 3.13%
1
2
3
4
5

Publishers

1
2
3
4
5
6
7
MDPI
7 publications, 21.88%
Springer Nature
7 publications, 21.88%
Elsevier
6 publications, 18.75%
Bentham Science Publishers Ltd.
4 publications, 12.5%
Wiley
2 publications, 6.25%
Walter de Gruyter
2 publications, 6.25%
Taylor & Francis
1 publication, 3.13%
American Chemical Society (ACS)
1 publication, 3.13%
1
2
3
4
5
6
7
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
32
Share
Cite this
GOST |
Cite this
GOST Copy
Aly A. M. et al. New quinoline-2-one/pyrazole derivatives; design, synthesis, molecular docking, anti-apoptotic evaluation, and caspase-3 inhibition assay // Bioorganic Chemistry. 2020. Vol. 94. p. 103348.
GOST all authors (up to 50) Copy
Aly A. M., Sayed S. M., Abdelhafez E. M. N., Abdel Hafez S. M. N., Abdelzaher W. Y., Raslan M. A., Ahmed A. S., Thabet K., El-Reedy A. A. M., Brown A., Bräse S. New quinoline-2-one/pyrazole derivatives; design, synthesis, molecular docking, anti-apoptotic evaluation, and caspase-3 inhibition assay // Bioorganic Chemistry. 2020. Vol. 94. p. 103348.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1016/j.bioorg.2019.103348
UR - https://doi.org/10.1016/j.bioorg.2019.103348
TI - New quinoline-2-one/pyrazole derivatives; design, synthesis, molecular docking, anti-apoptotic evaluation, and caspase-3 inhibition assay
T2 - Bioorganic Chemistry
AU - Aly, Ashraf M.
AU - Sayed, Samia M
AU - Abdelhafez, Elshimaa M N
AU - Abdel Hafez, Sara Mohamed Naguib
AU - Abdelzaher, Walaa Yehia
AU - Raslan, Mohamed A.
AU - Ahmed, Amira S.
AU - Thabet, Khaled
AU - El-Reedy, Ahmed A. M.
AU - Brown, Alan
AU - Bräse, Stefan
PY - 2020
DA - 2020/01/01
PB - Elsevier
SP - 103348
VL - 94
PMID - 31699387
SN - 0045-2068
SN - 1090-2120
ER -
BibTex
Cite this
BibTex (up to 50 authors) Copy
@article{2020_Aly,
author = {Ashraf M. Aly and Samia M Sayed and Elshimaa M N Abdelhafez and Sara Mohamed Naguib Abdel Hafez and Walaa Yehia Abdelzaher and Mohamed A. Raslan and Amira S. Ahmed and Khaled Thabet and Ahmed A. M. El-Reedy and Alan Brown and Stefan Bräse},
title = {New quinoline-2-one/pyrazole derivatives; design, synthesis, molecular docking, anti-apoptotic evaluation, and caspase-3 inhibition assay},
journal = {Bioorganic Chemistry},
year = {2020},
volume = {94},
publisher = {Elsevier},
month = {jan},
url = {https://doi.org/10.1016/j.bioorg.2019.103348},
pages = {103348},
doi = {10.1016/j.bioorg.2019.103348}
}